A mathematical model for the treatment of chronic myeloid leukemia (CML) through a combination of tyrosine kinase inhibitors and immunomodulatory therapies is analyzed as a dynamical system for the case of constant drug concentrations. Equilibria and their stability are determined and it is shown that, depending on the parameter values, the model exhibits a variety of behaviors which resemble the chronic, accelerated and blast phases typical of the disease. This work provides qualitative insights into the system which should be useful for understanding the interaction between CML and the therapies considered here
A simulative study of cancer growth dynamics in patients affected by Chronic Myeloid Leukemia (CML),...
In this paper, a model describing the dynamic of chronic myeloid leukemia is studied. By analyzing t...
The objective of this PhD is the study of chronic myeloid leukemia (CML), chronic Lymphoid leukemia ...
International audienceWe propose and analyze a simplified version of a partial differential equation...
Chronic Myelogenous Leukemia (CML) is one of the most common types of leukemia. It is characterized ...
International audienceWe describe here a simple model for the interaction between leukemic cells and...
Chronic myelogenous leukemia (CML) is a cancer of the blood, and the im-mune system is known to play...
In this paper, we consider a system of nonlinear delay-differential equations (DDEs) which models th...
We propose and analyze a system of partial differential equations (PDEs) for chronic myeloid leukemi...
Background. Recent mathematical models have been developed to study the dynamics of chronic myelogen...
Targeted inhibition of the oncogenic BCR-ABL1 fusion protein using the ABL1 tyrosine kinase inhibito...
The evolutionary dynamics of cancerous cell populations in a model of Chronic Myeloid Leukemia (CML)...
Cette thèse porte sur la dynamique de modèles de leucémie myéloïde chronique (LMC). Les modèles qui ...
This thesis deals with the dynamics of models of chronic myeloid leukemia (CML). Models of interest ...
Targeted inhibition of the oncogenic BCR-ABL1 fusion protein using the ABL1 tyrosine kinase inhibito...
A simulative study of cancer growth dynamics in patients affected by Chronic Myeloid Leukemia (CML),...
In this paper, a model describing the dynamic of chronic myeloid leukemia is studied. By analyzing t...
The objective of this PhD is the study of chronic myeloid leukemia (CML), chronic Lymphoid leukemia ...
International audienceWe propose and analyze a simplified version of a partial differential equation...
Chronic Myelogenous Leukemia (CML) is one of the most common types of leukemia. It is characterized ...
International audienceWe describe here a simple model for the interaction between leukemic cells and...
Chronic myelogenous leukemia (CML) is a cancer of the blood, and the im-mune system is known to play...
In this paper, we consider a system of nonlinear delay-differential equations (DDEs) which models th...
We propose and analyze a system of partial differential equations (PDEs) for chronic myeloid leukemi...
Background. Recent mathematical models have been developed to study the dynamics of chronic myelogen...
Targeted inhibition of the oncogenic BCR-ABL1 fusion protein using the ABL1 tyrosine kinase inhibito...
The evolutionary dynamics of cancerous cell populations in a model of Chronic Myeloid Leukemia (CML)...
Cette thèse porte sur la dynamique de modèles de leucémie myéloïde chronique (LMC). Les modèles qui ...
This thesis deals with the dynamics of models of chronic myeloid leukemia (CML). Models of interest ...
Targeted inhibition of the oncogenic BCR-ABL1 fusion protein using the ABL1 tyrosine kinase inhibito...
A simulative study of cancer growth dynamics in patients affected by Chronic Myeloid Leukemia (CML),...
In this paper, a model describing the dynamic of chronic myeloid leukemia is studied. By analyzing t...
The objective of this PhD is the study of chronic myeloid leukemia (CML), chronic Lymphoid leukemia ...